Log in to save to my catalogue

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with h...

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3674020

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension

About this item

Full title

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension

Publisher

New Zealand: Dove Medical Press Limited

Journal title

International journal of general medicine, 2013-01, Vol.6, p.405-411

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Irbesartan has been reported to have beneficial effects on glucose/lipid metabolism in addition to an antihypertensive effect; however, such effects have not been clarified in hemodialysis (HD) patients. We investigated the effects of irbesartan on blood pressure (BP) as well as glucose/lipid metabolism, in HD patients with hypertension.
Sevente...

Alternative Titles

Full title

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3674020

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3674020

Other Identifiers

ISSN

1178-7074

E-ISSN

1178-7074

DOI

10.2147/IJGM.S43850

How to access this item